Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016–2032

Silvia Martínez-Valverde, Rodrigo Zepeda-Tello, Angélica Castro-Ríos, Filiberto Toledano-Toledano, Hortensia Reyes-Morales, Adrián Rodríguez-Matías and Juan Luis Gerardo Durán-Arenas
Additional contact information
Silvia Martínez-Valverde: Centro de Estudios Económicos y Sociales en Salud, Hospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City 06720, Mexico
Rodrigo Zepeda-Tello: Dirección de Prestaciones Económicas y Sociales, Instituto Mexicano del Seguro Social, Mexico City 06600, Mexico
Angélica Castro-Ríos: Unidad de Investigación en Epidemiología Clínica, Hospital de Pediatría, Centro Médico Nacional SXXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico
Filiberto Toledano-Toledano: Unidad de Investigación en Medicina Basada en Evidencias, Hospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City 06720, Mexico
Hortensia Reyes-Morales: Centro de Investigación en Sistemas de Salud, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico
Adrián Rodríguez-Matías: Servicio de Nefrología, Hospital Angeles Metropolitano, Mexico City 06760, Mexico
Juan Luis Gerardo Durán-Arenas: Departamento de Salud Pública, Facultad de Medicina, Universidad Autónoma de México, Mexico City 04510, Mexico

IJERPH, 2022, vol. 19, issue 15, 1-12

Abstract: Health needs assessment is a relevant tracer of planning process of healthcare programs. The objective is to assess the health needs of chronic kidney disease (CKD) secondary to type 2 diabetes mellitus (T2 DM) in a population without social security in Mexico. The study design was a statistical simulation model based on data at the national level of Mexico. A stochastic Markov model was used to simulate the progression from diabetes to CKD. The time horizon was 16 years. The results indicate that in 2022, kidney damage progression and affectation in the diabetic patient cohort will be 34.15% based on the time since T2 DM diagnosis. At the end of the 16-year period, assuming that the model of care remains unchanged, early renal involvement will affect slightly more than twice as many patients (118%) and cases with macroalbuminuria will triple (228%). The need for renal replacement therapy will more than double (169%). Meanwhile, deaths associated with cardiovascular risk will more than triple (284%). We concluded that the clinical manifestations of patients with CKD secondary to T2 DM without social security constitute a double challenge. The first refers to the fact that the greatest health need is early care of CKD, and the second is the urgent need to address cardiovascular risk in order to reduce deaths in the population at risk.

Keywords: chronic kidney disease; health needs; Markov model; diabetes mellitus; Mexico; assessment (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/15/9010/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/15/9010/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:15:p:9010-:d:870679

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().